Strategic Growth AI helps global pharma, biotech, medtech, and AI-health companies launch and scale in Canada through tailored licensing, commercialization, and market optimization partnerships.
​
We align regulatory strategy, payer evidence, and go-to-market execution to:
-
Increase Probability of Success (PoS)
-
Accelerate HTA and reimbursement timelines
-
De-risk market entry and expansion across Canada and the U.S.
​​
Our Clarity Intelligence™ platform combines human-in-the-loop analytics, Monte Carlo scenario bands, and operator-led execution to prioritize:
-
Indication sequencing
-
Price corridor design
-
Access pathway development
​​
Outcome: Pilots that convert into reimbursed revenue—faster, with lower risk and investor-grade forecast clarity.
We partner with innovators to deliver differentiated products into the Canadian market via:
​
-
In-licensing of Pharmaceuticals, Biologics, SaMD, and Digital Health solutions
-
Full-service commercialization for market-ready and post-approval assets
-
Market entry and infrastructure build-out for companies seeking direct Canadian presence
​​
Our commercialization division also specializes in:
-
Revitalizing Mature Brands to extend lifecycle and unlock residual value
-
Repositioning Underpromoted Assets with high-ROI marketing and promotion
-
Optimizing Legacy Products for loyal prescriber retention and formulary continuity
​​
We tailor our approach to fit the product lifecycle stage, regulatory status, and commercial ambition of each partner.​
Business Development
​
Our BD team forges high-trust collaborations across the Canadian healthcare landscape:
-
Clinicians & KOLs to drive awareness and adoption
-
Payers & Policymakers – to secure reimbursement and coverage
-
Distributors, PSPs, and Specialty Pharmacies – to enable seamless patient access
-
Government & Innovation Hubs – to align with policy and procurement trends
Through flexible licensing, co-promotion, and BOT commercialization models, we help our partners expand their impact and optimize market performance.
​
Strategic Focus
​
We prioritize:
-
Products not yet launched in Canada
-
Late-stage or recently approved innovations ready for commercial execution
-
Solutions that address unmet clinical needs or reduce system burden
-
Opportunities aligned with our internal infrastructure and payer pathways
Our mandate is to ensure life-changing therapies reach Canadian patients, with speed, safety, and measurable ROI.
​
Sales & Marketing Execution
​
Our dedicated commercial team brings deep launch experience across Canada’s unique healthcare ecosystem.
We support:
-
Brand strategy, messaging, and KOL alignment
-
Sales team build-out or co-promotion
-
Digital and clinical engagement campaigns
-
Channel coordination with PSPs and specialty pharmacies
​​
Whether building from scratch or scaling an existing footprint, we ensure your brand earns trust and traction.
Therapeutic Focus Areas
​
-
Rare Disease
-
Specialty Therapeutics
-
Oncology Support
-
Endocrinology / Metabolic Health
-
Mental Health & Women’s Health
-
Respiratory / Cardio-Metabolic
-
AI-enabled Primary Care / Digital Health
​​
Reimbursement & Market Access
We specialize in Canadian market access, with proven success across:
-
HTA Navigation – CADTH, INESSS, and provincial processes
-
Pricing Strategy – PMPRB guidance, cost-utility positioning
-
pCPA Negotiations – maximizing access without margin erosion
From submission through implementation, we support every phase of the reimbursement journey — ensuring pricing compliance, faster time-to-coverage, and sustainable national adoption.
Our track record includes favorable assessments, optimized pricing bands, and accelerated public plan inclusion.
​
Regulatory Strategy & Compliance
​
Our regulatory affairs team provides:
-
Full-spectrum Health Canada submission management (NDS, SaMD, Class II/III)
-
Labeling, pharmacovigilance, and post-market compliance
-
Expertise in evolving PMPRB, digital health, and AI governance frameworks
We maintain proactive alignment with Health Canada and market standards to streamline approvals and avoid costly delays.​
​
Our leadership team brings decades of hands-on success across go-to-market execution, regulatory strategy, clinical development, and product commercialization, spanning both breakthrough innovations and mature brand portfolios.
​
We partner with SMEs and global leaders in pharma, biotech, AI-health, and medTech to unlock revenue and market share in Canada. From strategic planning to hands-on execution, we accelerate adoption, reimbursement, and real-world impact, backed by deep expertise and a high-trust national network.
​
Let’s explore how we can help you scale in Canada faster, safer, and with measurable ROI.
​
Professional Networks
UBC Entrepreneurship • BC Tech • AIinBC • Life Sciences BC • Healthtech Partnering